This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

AMAG Pharmaceuticals Inc (AMAG)

: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 228.71M 119.30M 26.99M 46.29M
Receivables 86.11M 42.69M 7.12M 6.67M
Inventories 40.65M 40.61M 17.22M 12.45M
Other Current Assets 0.00 0.00 0.00 2.00M
Total Current Assets 606.67M 274.04M 244.41M 254.38M
Property, Plant & Equipment, Gross 33.60M 2.50M 2.34M 11.04M
Accumulated Depreciation & Depletion 4.88M 978.00K 496.00K 7.75M
Property, Plant & Equipment, Net 28.73M 1.52M 1.85M 3.30M
Intangibles 1.20B 887.91M 16.84M 0.00
Other Non-Current Assets 16.07M 19.65M 2.36M 460.00K
Total Non-Current Assets 1.88B 1.11B 21.05M 3.76M
Liabilities & Shareholder Equity
Total Assets 2.49B 1.39B 265.46M 258.14M
Accounts Payable 4.91M 7.30M 2.63M 3.52M
Short Term Debt 17.50M 34.00M 0.00 0.00
Other Current Liabilities 96.97M 0.00 0.00 0.00
Total Current Liabilities 245.92M 166.49M 33.12M 32.96M
Long Term Debt 985.64M 461.35M 0.00 0.00
Deferred Income Taxes 189.15M 77.62M 0.00 2.03M
Other Non-Current Liabilities 134.46M 223.53M 59.93M 50.35M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 1.31B 762.49M 59.93M 52.38M
Total Liabilities 1.56B 928.98M 93.05M 85.34M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 932.26M 459.95M 172.41M 172.80M
Common Par 347.00K 256.00K 218.00K 215.00K
Additional Paid In Capital 1.23B 793.76M 641.94M 632.49M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -297.66M -330.44M -466.26M -456.66M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -4.21M -3.62M -3.49M -3.25M
Total Capitalization 1.92B 921.30M 172.41M 172.80M
Total Equity 932.26M 459.95M 172.41M 172.80M
Total Liabilities & Stock Equity 2.49B 1.39B 265.46M 258.14M
Total Common Shares Outstanding 34.73M 25.60M 21.77M 21.51M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 9.13M 0.00 0.00 0.00
Basic Weighted Shares Outstanding 31.47M 22.42M 21.70M 21.39M
Diluted Weighted Shares Outstanding 35.31M 25.23M 21.70M 21.39M
Number of Employees 552 257 148 129
Number of Part-Time Employees 0 0 0 0
AMAG News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

AMAG AMAG Pharmaceuticals Inc

Chart of AMAG

Analysts Ratings for AMAG

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 5 5
Moderate Buy 1 1 1 1
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET AMAG ANALYST REPORT

AMAG Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs